María De Arcocha Torres

María de Arcocha is Head of Radiophamacy Unit at Marqués de Valdecilla University Hospital. EDUCATION 2004 Degree in Pharmacy. University of Basque Country, Vitoria, Spain. 2007 Radiopharmacy Specialist, Virgen de las Nieves University Hospital of Granada, Spain. 2007 Advanced Studies Diploma, University of Granada, Spain. 2008 Master in Regenerative Biomedicine. 2017 Grade D in animal experimentation. CAREER PROFILE Radiopharmacyst at the IBA Molecular cyclotron, Sevilla, Spain. July 2007-December 2007. Pharmaceutical Technical Director at Molypharma cycloton. Santander, Spain. January 2008-August 2009. Head of Radiophamacy Unit at the Marqués de Valdecilla University Hospital of Santander, Spain, since september 2009. President of the Spanish Society of Radiopharmacy. 2012-2014. Member of the Molecular Imaging Group of IDIVAL since 2014 Reviewer of the journal "Revista Española de Medicina Nuclear e Imagen Molecular". Member of the Committee of Quality in Nuclear Medicine at the Marqués de Valdeculla University Hospital of Santander, Spain. Member of Oncology workgroup of Spanish Society of Nuclear Medicine and Molecular Imaging. Member of National Radiopharmacy Commission. Author or co-author of more than 30 peer-reviewed scientific articles, and more than 90 contributions to scientific congresses, as well as several book chapters. Participation in 4 competitive research projects as principal investigator or collaborator. Principal investigator of NEXTVAL project. RESEARCH INTERESTS: Synthesis and Quality control of PET radiopharmaceuticals; Synthesis and Quality control of SPECT radiopharmaceuticals; Development of new molecules; Good Manufacturing Practises; Process validation and therapy radiopharmaceuticals